+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Biosynthesis of silver nanoparticles using Myristica fragrans seed (nutmeg) extract and its antibacterial activity against multidrug-resistant (MDR) Salmonella enterica serovar Typhi isolates



Biosynthesis of silver nanoparticles using Myristica fragrans seed (nutmeg) extract and its antibacterial activity against multidrug-resistant (MDR) Salmonella enterica serovar Typhi isolates



Environmental Science and Pollution Research International 24(17): 14758-14769



Biosynthesis of nanoparticles has received increasing attention due its effective mode of action, eco-friendly preparation methodology, and less cytotoxicity. In the present study, silver nanoparticles (AgNPs) from aqueous seed extract of Myristica fragrans (nutmeg) were characterized. Gas chromatography-mass spectrometry (GC-MS) analysis revealed the presence of bioactive components acts as effective in reducing and capping agents for converting AgNO3 to AgNPs. The UV-Vis absorption spectrum of the biologically reduced reaction mixture showed the surface plasmon peak at 420 nm, which is the characteristic peak of AgNPs. The functional molecules present in the M. fragrans seed extract and their interaction with the AgNPs were identified by the Fourier transform infrared spectroscopy (FT-IR) analysis. X-ray diffraction (XRD) analysis confirmed the face-centered cubic crystalline structure of metallic silver nanoparticle and diameter was calculated using Scherrer's equation. Transmission electron microscope (TEM) image showed spherical shaped particles with an average size of 25 nm. The scanning electron microscopy-energy dispersive spectroscopy (SEM-EDS) confirmed the presence of elemental silver. The antibacterial activity of biosynthesized AgNPs was evaluated against multidrug-resistant (MDR) Salmonella enterica serovar Typhi (S. Typhi) according to agar well diffusion, MIC (minimum inhibitory concentration), and IC50 (inhibitory concentration 50%). The results confirm that bacterial growth was significantly reduced in a dose-dependent manner. Further, the cytotoxic effect of biosynthesized AgNPs on rat spleenocytes was analyzed. Thus, it is suggested that the nutmeg-biosynthesized AgNPs could be a lead drug and used effectively to control the MDR S. Typhi, thereby reducing public health issues and environmental pollution.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 059449253

Download citation: RISBibTeXText

PMID: 28470497

DOI: 10.1007/s11356-017-9065-7


Related references

Multidrug-resistant Salmonella enterica serovar typhi isolates with high-level resistance to ciprofloxacin in Dhaka, Bangladesh. Antimicrobial Agents and ChemoTherapy 50(10): 3516-3517, 2006

Genomic signature of multidrug-resistant Salmonella enterica serovar typhi isolates related to a massive outbreak in Zambia between 2010 and 2012. Journal of Clinical Microbiology 53(1): 262-272, 2015

Studies on the antibacterial activity of Khaya senegalensis [(Desr.) A. Juss)] stem bark extract on Salmonella enterica subsp. enterica serovar Typhi [(ex Kauffmann and Edwards) Le Minor and Popoff. Asian Pacific Journal of Tropical Biomedicine 4(Suppl 1): S279-S283, 2014

Multidrug-resistant Salmonella enterica serovar paratyphi A harbors IncHI1 plasmids similar to those found in serovar typhi. Journal of Bacteriology 189(11): 4257-4264, 2007

Multidrug resistant Salmonella enterica serovar typhi. Jnma; Journal of the Nepal Medical Association 48(174): 196-197, 2010

Emergence of multidrug-resistant Salmonella enterica serovar typhi in Korea. Antimicrobial Agents and ChemoTherapy 48(11): 4130-4135, 2004

Genotypic analysis of multidrug-resistant Salmonella enterica Serovar typhi, Kenya. Emerging Infectious Diseases 6(6): 649-651, 2000

Characterization of emerging multidrug-resistant Salmonella enterica serovar typhi in Korea. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 43: 126, 2003

Successful Therapy of a Multidrug-Resistant Extended-Spectrum β-Lactamase-Producing and Fluoroquinolone-Resistant Salmonella enterica Subspecies enterica Serovar Typhi Infection Using Combination Therapy of Meropenem and Fosfomycin. Clinical Infectious Diseases 65(10): 1754-1756, 2017

Molecular characterization of multidrug-resistant Salmonella enterica subsp. enterica serovar Typhimurium isolates from swine. Journal of Clinical Microbiology 40(8): 2813-2822, 2002

Analysis of plasmid and chromosomal DNA of multidrug-resistant Salmonella enterica serovar typhi from Asia. Journal of Clinical Microbiology 38(4): 1449-1452, 2000

A case of multidrug-resistant Salmonella enterica serovar Typhi treated with a bench to bedside approach. Yonsei Medical Journal 50(1): 147-151, 2009

Emergence of multidrug-resistant Salmonella enterica serovar Typhi with reduced susceptibility to fluoroquinolones in Cambodia. Diagnostic Microbiology and Infectious Disease 66(2): 207-209, 2010

Typhoid in Kenya is associated with a dominant multidrug-resistant Salmonella enterica serovar Typhi haplotype that is also widespread in Southeast Asia. Journal of Clinical Microbiology 48(6): 2171-2176, 2010

Antimicrobial susceptibility of travel-related Salmonella enterica serovar Typhi isolates detected in Switzerland (2002-2013) and molecular characterization of quinolone resistant isolates. Bmc Infectious Diseases 15: 212, 2015